Severe Meningococcal Meningitis Revealing a Novel Form of Properdin Deficiency in a Previously Healthy 13-year-old Child.
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
10 May 2024
10 May 2024
Historique:
medline:
16
5
2024
pubmed:
16
5
2024
entrez:
16
5
2024
Statut:
aheadofprint
Résumé
A 13-year-old boy was admitted with severe meningococcal meningitis. Immunologic workup revealed a properdin deficiency, and genetic sequencing of CFP identified a novel, private and predicted pathogenic variant in exon 8. The patient received broad immunizations and penicillin prophylaxis. Children with invasive meningococcal disease should be tested for complement deficiency.
Identifiants
pubmed: 38753997
doi: 10.1097/INF.0000000000004397
pii: 00006454-990000000-00866
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Wang B, Santoreneos R, Giles L, et al. Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine. 2019;37:2768–2782.
ECDC. Invasive Meningococcal Disease. Stockholm; 2022.
Parikh SR, Campbell H, Bettinger JA, et al. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect. 2020;81:483–498.
Pettigrew HD, Teuber SS, Gershwin ME. Clinical significance of complement deficiencies. Ann N Y Acad Sci. 2009;1173:108–123.
Emonts M, Hazelzet JA, de Groot R, et al. Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis. 2003;3:565–577.
Skattum L, van Deuren M, van der Poll T, et al. Complement deficiency states and associated infections. Mol Immunol. 2011;48:1643–1655.
Rosain J, Hong E, Fieschi C, et al. Strains responsible for invasive meningococcal disease in patients with terminal complement pathway deficiencies. J Infect Dis. 2017;215:1331–1338.
Fearon DT, Austen KF. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. J Exp Med. 1975;142:856–863.
Sjoholm AG, Braconier JH, Soderstrom C. Properdin deficiency in a family with fulminant meningococcal infections. Clin Exp Immunol. 1982;50:291–297.
Linton SM, Morgan BP. Properdin deficiency and meningococcal disease--identifying those most at risk. Clin Exp Immunol. 1999;118:189–191.
Fijen CA, Kuijper EJ, te Bulte MT, et al. Assessment of complement deficiency in patients with meningococcal disease in the Netherlands. Clin Infect Dis. 1999;28:98–105.
Sjoholm AG. Inherited complement deficiency states: implications for immunity and immunological disease. APMIS. 1990;98:861–874.
El Sissy C, Rosain J, Vieira-Martins P, et al. Clinical and genetic spectrum of a large cohort with total and sub-total complement deficiencies. Front Immunol. 2019;10:1936.
HAS. Recommandation vaccinale contre les méningocoques des sérogroupes A, C, W et Y 2021. Available at:www.has-sante.fr/upload/docs/application/pdf/2021-03/reommandation_vaccinale_contre_les_meningocoques_des_serogroupes_a_c_w_et_y_synthese.pdf
Fijen C, Van Den Bogaard R, Schipper M, et al. Properdin deficiency: molecular basis and disease association. Mol Immunol. 1999;36:863–867.